Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization

N Rama, A Dubrac, T Mathivet, RA Ní Chárthaigh… - Nature medicine, 2015 - nature.com
N Rama, A Dubrac, T Mathivet, RA Ní Chárthaigh, G Genet, B Cristofaro, L Pibouin-Fragner
Nature medicine, 2015nature.com
Ocular neovascular diseases are a leading cause of blindness. Vascular endothelial growth
factor (VEGF) blockade improves vision, but not all individuals respond to anti-VEGF
treatment, making additional means to prevent neovascularization necessary. Slit-family
proteins (Slits) are ligands of Roundabout (Robo) receptors that repel developing axons in
the nervous system. Robo1 expression is altered in ocular neovascular diseases, and
previous in vitro studies have reported both pro-and anti-angiogenic effects of Slits …
Abstract
Ocular neovascular diseases are a leading cause of blindness. Vascular endothelial growth factor (VEGF) blockade improves vision, but not all individuals respond to anti-VEGF treatment, making additional means to prevent neovascularization necessary. Slit-family proteins (Slits) are ligands of Roundabout (Robo) receptors that repel developing axons in the nervous system. Robo1 expression is altered in ocular neovascular diseases, and previous in vitro studies have reported both pro- and anti-angiogenic effects of Slits. However, genetic evidence supporting a role for Slits in ocular neovascularization is lacking. Here we generated conditional knockout mice deficient in various Slit and Robo proteins and found that Slit2 potently and selectively promoted angiogenesis via Robo1 and Robo2 in mouse postnatal retina and in a model of ocular neovascular disease. Mechanistically, Slit2 acting through Robo1 and Robo2 promoted the migration of endothelial cells. These receptors are required for both Slit2- and VEGF-induced Rac1 activation and lamellipodia formation. Thus, Slit2 blockade could potentially be used therapeutically to inhibit angiogenesis in individuals with ocular neovascular disease.
nature.com